Archives

by in
Entry Author Date Location
Dendritic Nanotechnologies Focuses Dendrimer Development On Industry Rather Than Pharma 05/07/10 Detroit
Averting “Disaster” in Healthcare: Xconomy Forum at MIT Tackles Big Problems and Potential Technology Fixes 04/28/10 Boston
Technology Alliance Showcases Five Companies in Sensors, Mobile Displays, and Drug Therapies: Investors Take Notice 04/22/10 Seattle
Anadys Reports Interim Hep C Drug Data, Ligand Collects Milestone Payment, Phenomix’s Diabetes Drug Shows Promise, & More San Diego Life Sciences News 04/22/10 San Diego
Amplyx Pharmaceuticals, Led By Women, Builds Platform for Improving Drugs for HIV, Cancer 04/20/10 San Diego
U.S. Chief Humanitarian: We Want to Buy Your Health Products For Poor Countries 03/17/10 Seattle
Genetix Pharma Raises $35M from Third Rock, Genzyme for Gene Therapy 03/12/10 Boston
Vertex Maps Out Combo Drug Game Plan for Treating Hepatitis C 03/08/10 Boston
Una Ryan Searching for Riches to Deliver Inexpensive Diagnostics to the Poor 03/05/10 Boston
Anadys Hepatitis C Drug Increases Punch Over Time (But So Does Placebo) 02/24/10 San Diego
Gilead Sciences Gets FDA Green Light To Sell Cystic Fibrosis Drug 02/23/10 Seattle
NanoString Chairman Bill Young Scopes Out Diagnostic Future, Considers Bay Area Expansion 02/19/10 Seattle
Bill Gates Posts Annual Letter, Backs Khosla 01/25/10 Seattle
Gilead Deepens Roots in Seattle, Seeks Long-Term Payoff From Lung Disease Research 01/13/10 Seattle
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO 01/07/10 Boston
The 12 Days of Xconomists: Leading Innovators Give Their Top Advances of the Past Decade 01/05/10 National
Top Five Medical Innovations of the 2000s (And One Big Concern) 12/29/09 National
The Top Five Biotech Innovations of the 2000s 12/15/09 Seattle
Seattle’s Kineta Rakes in Half of $13M Federal Contract to UW For Vaccine Boosters 11/10/09 Seattle
Concert Starts HIV Trial, Bags $12M From Glaxo to Help Challenge Gilead’s Once-Daily Pill 11/09/09 Boston
Combination Drugs Are The Future for Hepatitis C 11/03/09 San Diego
UW Scientists, Backed by Gates Foundation, Enter “Put Up or Shut Up” Phase with Portable Diagnostic 11/03/09 Seattle
Virdante Pharma Lands $30M in A Round to Combat Inflammation 10/29/09 Boston
Vertex Hepatitis C Drug Wipes Out Virus For Toughest-to-Treat Patients 10/28/09 Boston
San Diego’s Ardea Biosciences Sees Potential for Gout Drug in Combination Treatment 10/19/09 San Diego
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News 10/08/09 Seattle
Seattle’s Theraclone Strikes $18M Deal to Make Flu-Fighting Antibodies with Japanese Company 10/05/09 Seattle
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News 10/01/09 Seattle
The Quest for an HIV Vaccine 09/29/09 Seattle
Targeted Genetics Lives On, CellCyte Charged With Fraud, Theraclone Finds HIV Weakness, & More Seattle-Area Life Sciences News 09/10/09 Seattle
Page 3 of 5 « previous page · next page »